Business
Notification of Interim Resul
Notification of Interim Resul.
About this update from Allergy Therapeutics Plc
[{"type":"text","content":"\n RNS Number : 8320F Allergy Therapeutics PLC 20 January 2010 \n\n\n\n\n\nWednesday 20 January 2010\n\n\nAllergy Therapeutics plc\n(\"Allergy Therapeutics\" or \"the Company\")\n\nNotification of Interim Results and Trading update\n \n \nAllergy Therapeutics plc (AIM: AGY), the specialist pharmaceutical company focused on allergy vaccination, will announce its interim results for the six months ended 31 December 2009 on 1 March 2010. The Company expects to report net sales of £27.3m; in line with market expectations.\n \nHistorically, Allergy Therapeutics' sales are heavily skewed towards the first half of the Company's financial year.\n \n\n\nFor further information\n\n\n\n\n\nAllergy Therapeutics\n\n\n+44 (0) 1903 845 821\n\n\n\n\nIan Postlethwaite\nFinance Director\n\n\n\n\n\n\n\nManuel Llobet\nChief Executive Officer\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nwww.allergytherapeutics.com\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNomura Code Securities\n\n\n+44 (0) 207 776 1200\n\n\n\n\nJuliet Thompson/ Clare Terlouw\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nThis information is provided by RNSThe company news service from the London Stock Exchange END TSTBMMPTMBITMAM\n ","length":4133,"tagName":"div"}]